Clinical Trials Logo

Clinical Trial Summary

This study evaluates hydration (1.5 L of water daily during 1 year) in the lowering of blood glucose concentration in adults with signs of dehydration (elevated levels of the vasopressin marker copeptin and high urine osmolality). Half of participants will in addition to lifestyle advice receive extra water on top of their habitual fluid intake, and the other half (control) will receive only lifestyle advice.


Clinical Trial Description

High plasma concentration of vasopressin (i.e. antidiuretic hormone) is a novel and independent risk factor for type 2 diabetes, the metabolic syndrome, cardiovascular disease and premature death. The main physiological role of vasopressin is to maintain constant plasma osmolality. Previous studies in rats and mendelian randomization studies in humans suggest causality between elevated vasopressin concentration and elevated plasma glucose concentration. As vasopressin can be suppressed by increasing water intake, we hypothesize that water supplementation in individuals with high vasopressin can lower plasma glucose and prevent diabetes. The aim of this project is to test in a single-centre randomized clinical trial (RCT), if water supplementation in subjects with high plasma levels of vasopressin (measured by a stable vasopressin marker of its precursor hormone called copeptin) can reduce fasting levels of glucose (primary outcome measure), risk of new-onset diabetes and other cardiometabolic risk factors (secondary outcome measures). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03422848
Study type Interventional
Source Region Skane
Contact Olle Melander, M.D., Prof
Phone +46 40 391209
Email olle.melander@med.lu.se
Status Recruiting
Phase N/A
Start date April 24, 2018
Completion date June 30, 2025

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04230694 - Continuous Glucose Monitoring of Hospitalized Patients With Diabetes N/A
Active, not recruiting NCT04641689 - Stand Up Kansas: An Intervention to Reduce Sedentary Behavior in the Home Work Environment N/A
Active, not recruiting NCT05056376 - Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs N/A
Completed NCT04547023 - Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy N/A
Completed NCT04648397 - The Effect of Chewing Duration on Blood Glucose Levels N/A
Enrolling by invitation NCT04846751 - Exercise Type That Faster Reduces Postprandial Glycemia. N/A
Active, not recruiting NCT04893148 - Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes Phase 4
Active, not recruiting NCT01028846 - Central Mechanisms That Regulate Glucose Metabolism in Humans Phase 4
Completed NCT03252704 - Post-prandial Glycemic Response to Fiber in Healthy Adults N/A
Completed NCT05215210 - The Effect of Long-term Momordica Charantia Supplementation on Blood Glucose Levels N/A
Completed NCT03972878 - Foodprint 1.0: Physiological Acute Responses After Consumption of Confectionary Products N/A
Completed NCT05071950 - The Effect of D-allulose on the Glycemic Changes in Patients With Type 2 Diabetes Mellitus During Ramadan Fasting N/A
Suspended NCT03428295 - Dose Safety Hybrid Closed Loop and Fully Automated Closed Loop Artificial Pancreas Device in CRC Phase 1/Phase 2
Suspended NCT03566511 - Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide Phase 2
Completed NCT04483453 - Effect of Nutritional Intervention on Metabolic Response in Infants N/A
Completed NCT03344185 - The Effect of Glycaemic Index Variation on Blood Glucose and Mood in Healthy Participants Across the Day N/A
Completed NCT03544411 - Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DM Phase 1
Completed NCT05182190 - Effects of Black Bean Pasta Consumption on Biomarkers in Young Adults N/A
Completed NCT04438018 - Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control in T2DM
Completed NCT03811132 - Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control (DIA-LINK Study)